224 related articles for article (PubMed ID: 33239505)
21. IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours.
Amary MF; Bacsi K; Maggiani F; Damato S; Halai D; Berisha F; Pollock R; O'Donnell P; Grigoriadis A; Diss T; Eskandarpour M; Presneau N; Hogendoorn PC; Futreal A; Tirabosco R; Flanagan AM
J Pathol; 2011 Jul; 224(3):334-43. PubMed ID: 21598255
[TBL] [Abstract][Full Text] [Related]
22. Conventional chondrosarcoma of the rib cage and sternum: clinicopathological and molecular analysis of 27 patients treated at a single institution.
Abdulfatah E; Rottmann D; Morag Y; Pantanowitz L; Udager AM; Hao W; Lucas DR
Hum Pathol; 2023 Jun; 136():63-74. PubMed ID: 37019410
[TBL] [Abstract][Full Text] [Related]
23. Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors.
Eefting D; Schrage YM; Geirnaerdt MJ; Le Cessie S; Taminiau AH; Bovée JV; Hogendoorn PC;
Am J Surg Pathol; 2009 Jan; 33(1):50-7. PubMed ID: 18852676
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic role of neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio in patients with enchondroma and low-grade chondrosarcoma.
Yapar A; Ulucaköy C; Sezgin EA; Atalay İB; Ekşioğlu MF
Jt Dis Relat Surg; 2020; 31(2):286-290. PubMed ID: 32584727
[TBL] [Abstract][Full Text] [Related]
25. Gadd45β expression in chondrosarcoma: a pilot study for diagnostic and biological implications in histological grading.
Zenmyo M; Tanimoto A; Sakakima H; Yokouchi M; Nagano S; Yamamoto T; Ishido Y; Komiya S; Ijiri K
Diagn Pathol; 2010 Oct; 5():69. PubMed ID: 20942912
[TBL] [Abstract][Full Text] [Related]
26. Enchondroma vs. chondrosarcoma: a simple, easy-to-use, new magnetic resonance sign.
Vanel D; Kreshak J; Larousserie F; Alberghini M; Mirra J; De Paolis M; Picci P
Eur J Radiol; 2013 Dec; 82(12):2154-60. PubMed ID: 22227263
[TBL] [Abstract][Full Text] [Related]
27. Enchondroma protuberans. Report of a case and its distinction from chondrosarcoma and osteochondroma adjacent to an enchondroma.
Crim JR; Mirra JM
Skeletal Radiol; 1990; 19(6):431-4. PubMed ID: 2218592
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
29. Conventional chondrosarcoma with focal clear cell change: a clinicopathological and molecular analysis.
Lam SW; van Langevelde K; Suurmeijer AJH; Cleven AHG; Bovée JVMG
Histopathology; 2019 Dec; 75(6):843-852. PubMed ID: 31297850
[TBL] [Abstract][Full Text] [Related]
30. Intracellular cholesterol biosynthesis in enchondroma and chondrosarcoma.
Zhang H; Wei Q; Tsushima H; Puviindran V; Tang YJ; Pathmanapan S; Poon R; Ramu E; Al-Jazrawe M; Wunder J; Alman BA
JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31039139
[TBL] [Abstract][Full Text] [Related]
31. Biomarkers of chondrosarcoma.
Jeong W; Kim HJ
J Clin Pathol; 2018 Jul; 71(7):579-583. PubMed ID: 29593061
[TBL] [Abstract][Full Text] [Related]
32. New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance.
Monderer D; Luseau A; Bellec A; David E; Ponsolle S; Saiagh S; Bercegeay S; Piloquet P; Denis MG; Lodé L; Rédini F; Biger M; Heymann D; Heymann MF; Le Bot R; Gouin F; Blanchard F
Lab Invest; 2013 Oct; 93(10):1100-14. PubMed ID: 23958880
[TBL] [Abstract][Full Text] [Related]
33. H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features.
Makise N; Sekimizu M; Konishi E; Motoi T; Kubo T; Ikoma H; Watanabe SI; Okuma T; Hiraoka N; Fukayama M; Kawai A; Ichikawa H; Yoshida A
Mod Pathol; 2019 Mar; 32(3):435-445. PubMed ID: 30291346
[TBL] [Abstract][Full Text] [Related]
34. Expression of connective tissue growth factor in cartilaginous tumors.
Shakunaga T; Ozaki T; Ohara N; Asaumi K; Doi T; Nishida K; Kawai A; Nakanishi T; Takigawa M; Inoue H
Cancer; 2000 Oct; 89(7):1466-73. PubMed ID: 11013359
[TBL] [Abstract][Full Text] [Related]
35. The role of Thallium-201 scintigraphy and Tc-99m pentavalent dimercaptosuccinic acid in diagnosis and grading of chondrosarcoma.
Jo O; Schlicht S; Slavin J; Di Bella C; Pang G; Powell G; Spelman T; Choong PF
Eur J Radiol; 2020 Apr; 125():108846. PubMed ID: 32062570
[TBL] [Abstract][Full Text] [Related]
36. Minichromosome maintenance protein (MCM6) in low-grade chondrosarcoma: distinction from enchondroma and identification of progressive tumors.
Helfenstein A; Frahm SO; Krams M; Drescher W; Parwaresch R; Hassenpflug J
Am J Clin Pathol; 2004 Dec; 122(6):912-8. PubMed ID: 15539383
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of mutant IDH1 decreases D-2-HG levels without affecting tumorigenic properties of chondrosarcoma cell lines.
Suijker J; Oosting J; Koornneef A; Struys EA; Salomons GS; Schaap FG; Waaijer CJ; Wijers-Koster PM; Briaire-de Bruijn IH; Haazen L; Riester SM; Dudakovic A; Danen E; Cleton-Jansen AM; van Wijnen AJ; Bovée JV
Oncotarget; 2015 May; 6(14):12505-19. PubMed ID: 25895133
[TBL] [Abstract][Full Text] [Related]
38. DNA flow cytometric analysis of chest-wall chondroma and chondrosarcoma.
Shih CS; Wang LS; Yang SS; Fahn HJ; Wu LH; Chen WY; Huang MH
Scand J Thorac Cardiovasc Surg; 1996; 30(3-4):157-61. PubMed ID: 8976036
[TBL] [Abstract][Full Text] [Related]
39. Radiographic Enchondroma Surveillance: Assessing Clinical Outcomes and Costs Effectiveness.
Akoh CC; Craig E; Troester AM; Miller BJ
Iowa Orthop J; 2019; 39(1):185-193. PubMed ID: 31413693
[TBL] [Abstract][Full Text] [Related]
40. Clonal chromosome abnormalities in enchondromas and chondrosarcomas.
Gunawan B; Weber M; Bergmann F; Wildberger J; Niethard FU; Füzesi L
Cancer Genet Cytogenet; 2000 Jul; 120(2):127-30. PubMed ID: 10942802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]